Publikationen in Zusammenarbeit mit Forschern von Duke University (4)

2014

  1. Emergent cardiac surgery during transcatheter aortic valve implantation (TAVI): Insights from the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry

    EuroIntervention, Vol. 10, Núm. 8, pp. 975-981

2010

  1. Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): A randomised factorial trial

    The Lancet, Vol. 376, Núm. 9748, pp. 1233-1243

2009

  1. Enoxaparin Versus Unfractionated Heparin in Elective Percutaneous Coronary Intervention. 1-Year Results From the STEEPLE (SafeTy and Efficacy of Enoxaparin in Percutaneous coronary intervention patients, an internationaL randomized Evaluation) Trial

    JACC: Cardiovascular Interventions, Vol. 2, Núm. 11, pp. 1083-1091

2006

  1. Enoxaparin versus unfractionated heparin in elective percutaneous coronary intervention

    New England Journal of Medicine, Vol. 355, Núm. 10, pp. 1006-1017